This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.0.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="cancer-related-medication-request-gefitinib"/>
<meta>
<profile
value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource "cancer-related-medication-request-gefitinib" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mcode-cancer-related-medication-request.html">Cancer-Related Medication Request Profile</a></p></div><p><b>Procedure Intent Extension</b>: Curative - procedure intent <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#373808002)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: gefitinib 250 MG Oral Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.0.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#349472)</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-john-anyperson.html">Patient/cancer-patient-john-anyperson</a> " ANYPERSON"</p><p><b>authoredOn</b>: 2019-04-01</p><p><b>requester</b>: <a href="Practitioner-us-core-practitioner-kyle-anydoc.html">Practitioner/us-core-practitioner-kyle-anydoc</a> " ANYDOC"</p><p><b>reasonCode</b>: Non-small cell lung cancer (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#254637007)</span></p></div>
</text>
<extension
url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="373808002"/>
<display value="Curative - procedure intent"/>
</coding>
</valueCodeableConcept>
</extension>
<status value="active"/>
<intent value="order"/>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="349472"/>
<display value="gefitinib 250 MG Oral Tablet"/>
</coding>
</medicationCodeableConcept>
<subject>
<reference value="Patient/cancer-patient-john-anyperson"/>
</subject>
<authoredOn value="2019-04-01"/>
<requester>
<reference value="Practitioner/us-core-practitioner-kyle-anydoc"/>
</requester>
<reasonCode>
<coding>
<system value="http://snomed.info/sct"/>
<code value="254637007"/>
<display value="Non-small cell lung cancer (disorder)"/>
</coding>
</reasonCode>
<dosageInstruction>
<text value="250mg orally once daily with or without food"/>
<timing>
<event value="2019-04-01"/>
<repeat>
<boundsPeriod>
<start value="2019-04-30"/>
</boundsPeriod>
<frequency value="1"/>
<period value="1"/>
<periodUnit value="d"/>
</repeat>
<code>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-GTSAbbreviation"/>
<code value="QD"/>
</coding>
</code>
</timing>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="26643006"/>
<display value="Oral use"/>
</coding>
</route>
<doseAndRate>
<doseQuantity>
<value value="250"/>
<unit value="mg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</doseQuantity>
</doseAndRate>
</dosageInstruction>
</MedicationRequest>